FQPL Pharma Leaders' National Meet Set for June 21

India Pharma Outlook Team | Tuesday, 17 June 2025

 FQPL Pharma Leaders' National Meet Set for June 21, India Pharma Outlook
  • FQPL National Meet to be held on June 21 at JSS College of Pharmacy
  • Industry giants like Dr. Reddy's, Cipla, Sun Pharma, and Biocon to participate
  • Focus on pharma quality, regulatory trends, Industry 4.0, and academia-industry synergy

The Forum for Quality Pharma Leaders (FQPL), will hold its national meeting on June 21 at the JSS College of Pharmacy at JSS Academy of Higher Education and Research (JSSAHER).

It is going to be a good consortium of a deep-dive discussion related to the issues of quality pharmacy, international regulatory authority-related practices, and strengthening the gap between the industry and academia.

Also Read: How Advanced Training Methods can Enhance Patient Care

The meeting will be inaugurated by JSSAHER Pro-Chancellor B. Suresh. Respected pharmaceutical companies such as Dr. Reddy's Laboratories, Cipla, Biocon, Sun pharma, Lupin, Micro Labs, Aragen and Syngene International are collaborating at the meeting.

T.M. Pramod Kumar, Principal, JSS College of Pharmacy, mentioned the national meeting will cover many topics of interest to the contemporary pharmaceutical scenario, such as challenges and opportunities in the pharmaceutical sector, technology and changing practices, regulatory inspections, cross contamination, global regulatory market expectations, Industry 4.0 technology, and innovations and increasingly automation to quality systems.

“The meet is a vital step towards integrating academic excellence with industrial expectations by creating a space for open dialogue among pharmaceutical quality leaders and young professionals, who aim to strengthen the foundation of quality assurance in the pharma ecosystem,” said Mr. Kumar.

There will be more than 100 delegates including quality assurance head, regulatory professionals, and other suitable academia from multiple locations in India. 

© 2025 India Pharma Outlook. All Rights Reserved.